Courtesy of Dr. Carlos Fava. Peripheral vascular disease in lower limbs is on the rise. Antegrade recanalization is associated with amputation and death, and therefore contraindicated. For a while we have been using the retrograde access when classic revascularization is not possible. Even though there is evidence in favor of this access, it is just<a href="https://solaci.org/en/2019/09/11/should-we-start-using-the-retrograte-access-in-critical-limb-ischemia/" title="Read more" >...</a>
Courtesy of Dr. Carlos Fava. The real incidence of peripheral artery (PAD) disease in TAVR remains unclear. Different reports still estimate it is between 10 and 46%, but they have shown it has a negative impact in evolution. 51,685 TAVR patients were analyzed. 12,740 of these patients presented PAD (24.6%). PAD patients tended to be<a href="https://solaci.org/en/2019/09/11/the-real-impact-of-peripheral-artery-disease-in-tavr/" title="Read more" >...</a>
Coronary artery bypass graft (CABG) anastomosed to one vessel with normal or nearly normal fractional flow reserve (FFR) have poorer graft patency at one year compared against anastomosed grafts to vessels with functionally significant lesions shown by FFR. However, the recent study FARGO (Fractional Flow Reserve Versus Angiography Randomization for Graft Optimization) did not show<a href="https://solaci.org/en/2019/08/16/ffr-to-predict-cabg-result-all-benefits-in-a-population-much-too-pure/" title="Read more" >...</a>
After 2 years, SOLACI returns to Bolivia to continue promoting the development of interventional cardiology in Latin America. Do not hesitate to participate in this important event that will undoubtedly be enriching for medical practice and, also, to improve the quality of life of patients in our region. Are you planning on participating in the<a href="https://solaci.org/en/2019/08/14/all-you-need-to-know-about-bolivia-sessions-2019/" title="Read more" >...</a>
Cardiovascular risk increases dramatically with over the years, which almost inevitable leads to treating the elderly with statins, based on risk. To prevent over treatment, we need to identify fragile patients (bed-ridden or with dementia), whose condition might make this treatment futile on the one hand, and on the other hand, patients who regardless their<a href="https://solaci.org/en/2019/07/26/how-to-prevent-pharmacological-overtreating-in-the-elderly/" title="Read more" >...</a>
The ProEducar Fellow Course is a special event designed for fellows or interventional trainees seeking to update their knowledge and perfect their skills on interventional cardiology. This intensive and quality event introduces four interventional modules focused on practice rather than theory, with step-by-step demonstrations, tips and secrets of the trade, and educational cases. The course<a href="https://solaci.org/en/2019/07/21/proeducar-2019-we-celebrate-10-years-of-continuous-interventional-education/" title="Read more" >...</a>
A most valuable event organized by SOLACI and the Bolivian Society of Cardiology (SOBOCAR) for all Latin American interventional cardiologists is almost upon us. The Bolivia Sessions will be held in Cochabamba, Bolivia, on August 23rd and 24th, 2019. This event will feature over 20 Latin American special guests and modules on: Acute coronary syndrome.<a href="https://solaci.org/en/2019/07/18/2019-bolivia-sessions-discover-the-scientific-program/" title="Read more" >...</a>
This new meta-analysis combines all randomized transcatheter aortic valve replacement (TAVR) vs. surgical aortic valve replacement trials and expands the scope of TAVR. Evidence across the range of risk studied supports a paradigm shift in patients with symptomatic severe aortic stenosis. The clinical superiority of TAVR compared with surgery has been demonstrated across the spectrum<a href="https://solaci.org/en/2019/05/30/europcr-2019-most-recent-tavr-meta-analysis-the-spectrum-of-treatment-reaches-all-patients/" title="Read more" >...</a>
Researchers behind this small study believe that fracturing the rigid calcium deposits on leaflets with this new device could delay the need for transcatheter aortic valve replacement (TAVR) or facilitate it. This device showed actual improvement of leaflet mobility together with mean gradient reduction. The Leaflex Performer system (Pi-Cardia) was used in 16 patients with<a href="https://solaci.org/en/2019/05/28/europcr-2019-leaflex-new-device-for-pre-tavr-calcium-fracture/" title="Read more" >...</a>
Many patients arrive to the cath lab for a diagnostic coronary angiography after an echo showing severe ventricular dysfunction, even in asymptomatic patients. In many occasions, their coronary arteries are normal, and in many others, we find coronary disease that is not enough to warrant such severe ventricular dysfunction. Patients with heart failure are frequently<a href="https://solaci.org/en/2019/05/17/nonobstructive-coronary-lesions-and-ventricular-dysfunction/" title="Read more" >...</a>